Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
12 participants
INTERVENTIONAL
2016-02-29
2016-06-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Effects of Caffeine on EEG Theta/Beta Ratio and Cognitive Control
NCT02940808
EEG Analytics to Determine Effectiveness of a tDCS Protocol
NCT03537885
The Effectiveness of Biofeedback for Individuals With Long-term Post-concussive Symptoms
NCT03338036
Neurofeedback-enhanced Mindfulness Meditation in Traumatic Brain Injury
NCT02615535
Continuous Quantified EEG in NeuroIntensive Care
NCT02901262
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Aims, research question and hypothesis The main aims of this study will be to evaluate the effects of a Neurofeedback training on reducing EEG theta/beta ratio in individuals having elevated baseline TBR. Furthermore, with a very second degree of importance, the investigators will test if a reduction in TBR increases cognitive performance on a response conflict task.
The research questions will be; can a TBR Neurofeedback training in healthy (non-ADHD) people with elevated TBR reduce TBR and (very much secondary) will the training perhaps increase cognitive performance on a response conflict task? If so we might continue with further studies to assess NFT effects on cognitive performance in CPA in healthy people. It is expected that TBR will reduce after training onset. Also, it is expected that performance on the interference task will improve after participants have started with the TBR Neurofeedback training.
Design The investigators will use a single blind case series multiple baseline design with a baseline varying prior to training onset. By randomizing 12 participants over three conditions of different training onset points in time, the investigators will use a variation in baseline which offers the possibility to differentiate between time effects of the Neurofeedback training. All participants will start with a three-session baseline phase which will include a session with questionnaires, interference task training (in order to quickly reach a learning effect ceiling to better be able to observe additional performance change after intervention) and a resting state EEG measurement followed by two other sessions of resting state EEG measurements and the interference task. Participants in group A will then continue with 14 sessions of TBR Neurofeedback training. Group B will receive six extra baseline EEG measurements before they continue with eight TBR Neurofeedback sessions. Group C on the other hand will only receive 14 placebo training sessions after the short baseline phase. Before every TBR Neurofeedbacktraining or placebo training, a four-minute EEG resting-state baseline measurement will be performed.
The minimal number of real training sessions (eight) are necessary for making it possible to observe the onset of an effect of the Neurofeedback training, based on previous studies using a TBR Neurofeedback training (e.g. Studer et al., 2014; Doppelmayr \& Weber, 2011; Leins et al., 2007; Gevensleben et al., 2009). Also, a higher number of training sessions is important to ensure that a possible delayed effect of the Neurofeedback training can still be observed.
Procedure Before the first lab session, the participants will be stratified randomly assigned to one of the three groups. All participants will visit the lab 17 times. During the first visit, participants will fill in an informed consent, demographic information and questionnaires. They will continue with a training for the letter string interference task to avoid learning effects. At the end of the first visit, EEG resting state will be measured. During the second and third visit, participants will only receive a resting state EEG measurement and perform the letter string interference task. In the sessions after these baseline measurements, participants will receive a 4 minute EEG eyes-open resting state measurement, following either TBR Neurofeedback training or a placebo training depending on the participant group. After the Neurofeedback training, resting state measurement or placebo training, participants will always perform the letter string interference task. Sessions will be (almost) daily and approximately take between 50-60 minutes; except for the first questionnaires/interference training session which will take 90 minutes. The complete experiment will therefore take 17-19 hours per participant in 4-6 weeks.
Materials and training Questionnaires The participants will complete demographic information and fill in the trait and state version of the State-Trait Anxiety Inventory (STAI-t, STAI-s; Spielberger, 1983; Van der Ploeg et al., 1981) adapted to only report about the past week before the first session, and the trait and state version of the Attentional Control Scale (ACS; Derryberry \& Reed, 2002). The STAI-t assesses trait anxiety (range 20-80), STAI-s assesses the participant's current state of anxiety, and the ACS assesses attentional inhibition, attentional shift, and the capacity to flexibly generate new thoughts (range 20-80). The internal consistency of these questionnaires is generally good. STAI- t, ACS-t and a demographic questionnaire will only be measured during the first session and during the last session (after the training). The STAI-s and ACS-s will be assessed on every session before the EEG measurement or training.
Letter string interference task
The Letter String interference task will be as in Bishop (2009) with the only difference that in this study the neutral trials will be left out as they have no informative value on cognitive interference.
Neurofeedback theta/beta ratio training. The TBR Neurofeedback signal will be given by means of a NeXus-4 amplifier and recording system (Mindmedia, The Netherlands). One Ag/AgCl disposable electrode will be applied on the participant's scalp between locations Cz and FCz. For a high-quality and accurate EEG measurement, 16 extra in-cap electrodes (BioSemi, The Netherlands) will be added on locations F3, Fz, F4, C3, Cz, C4, P3, Pz, P4, T7, TP7, T8, TP8, O1, Oz and O2) during every session. Each session will consist of a four-minute resting state measurement, followed by a 25 minute measurement/Neurofeedback training or placebo training. The thresholds will be set 20% above (beta) or below (theta) the participant's amplitude, calculated and adjusted automatically every 15 seconds. During the training, theta and beta activity will be visualized in separate bar graphs on the screen and participants will be instructed to "try to move down the theta activity and move up the beta activity below or above the threshold". No instructions about how to influence their activity will be given. When the EEG theta power goes below the threshold, and the beta power above its threshold simultaneously, the participant will be rewarded by the continuation of a video. If they fail to reach this point, the video will be paused.
The placebo training will be a previously recorded Neurofeedback session of a participant in group A (receiving 14 real Neurofeedback sessions). Before the participants in group C (placebo trainings) start, they will be matched to a participant in group A, and receive the exact same (prerecorded) feedback per session of their matched participant. In this way, participants in the placebo training are then made to think that the video and EEG feedback is their own, however they are actually not able to influence the continuation of the video.
Data analysis For interpreting the results, visual inspection will be primarily used to determine the effectiveness of the TBR Neurofeedback training. If TBR in group A reduces after the introduction of the real Neurofeedback training compared to no changes in group C, the experiment provides compelling evidence for the effectiveness of the Neurofeedback training. The effect will be even more strongly supported if we see a similar reduction after Neurofeedback training onset in group A and B (as in after an equal number of actual NFT sessions as in group A, regardless the longer duration of the baseline). These changes after onset in group A and group B are assumed to be absent in group C, where we expect no changes at all. The expected effect in group B can also be considered as a direct replication of the effect in group A. The idealized expected changes in TBR are depicted in Figure 3 (each individual line represents changes in TBR per group). These visual inspections serve as testing of the primary outcome measures.
In addition to the primary test by visual inspection, secondary, we will perform statistical tests between the average TBR of group A and B together on an equal number of sessions after training onset compared to group C on the same number of sessions as group A (i.e. session 10 for group A averaged with session 14 for group B compared to session 10 for group C). Also, we will calculate eight separate contrast scores of average TBR within group A of session 1 minus session 17; session 2 minus session 16; session 3 minus session 15 etc. The same will be done for group B and C followed by a statistical comparison of the contrast scores of group A and B (taken together as one group) with the contrast scores of group C.
Tertiary, only in the case that in group A there seems to be evidence of change in TBR at approximately the same session in time as per visual inspection,, we will test a direct replication of this effect in group B using a similar permutation testing method as Ter Kuile et al., (2009, see also Bulté and Onghena, 2008 ) The approximate time-point of TBR change in group A might serve to designate the per-session TBR data as either pre- or post-intervention.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
BASIC_SCIENCE
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Group A: Theta/beta ratio Neurofeedback
In this condition, participants will receive three baseline sessions and continue with 14 theta/beta ratio Neurofeedback sessions.
Theta beta ratio Neurofeedback signal will be used to simultaneously down-train the EEG theta frequency band and up-train the beta frequency band. Three baseline sessions and continue with 14 theta/beta ratio Neurofeedback sessions.
Neurofeedback
Neurofeedback theta/beta ratio training. See 'Neurofeedback theta/beta ratio training' in detailed study description.
Group B: Theta/beta ratio Neurofeedback
In this condition, participants will receive nine baseline sessions and continue with eight theta/beta ratio Neurofeedback sessions.
Theta beta ratio Neurofeedback signal will be used to simultaneously down-train the EEG theta frequency band and up-train the beta frequency band. Three baseline sessions and continue with 14 theta/beta ratio Neurofeedback sessions.
Neurofeedback
Neurofeedback theta/beta ratio training. See 'Neurofeedback theta/beta ratio training' in detailed study description.
Group C: Placebo Neurofeedback training
Three baseline sessions and continue with 14 placebo training sessions. The placebo training will be a previously recorded Neurofeedback session of a participant in group A (receiving 14 real Neurofeedback sessions). Before the participants in group C (placebo trainings) start, they will be matched to a participant in group A, and receive the exact same (prerecorded) feedback per session of their matched participant. In this way, participants in the placebo training are then made to think that the video and EEG feedback is their own, however they are actually not able to influence the continuation of the video.
Placebo Neurofeedback training
The placebo training will be a previously recorded Neurofeedback session of a participant in group A
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Neurofeedback
Neurofeedback theta/beta ratio training. See 'Neurofeedback theta/beta ratio training' in detailed study description.
Placebo Neurofeedback training
The placebo training will be a previously recorded Neurofeedback session of a participant in group A
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
19 Years
23 Years
FEMALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Leiden University Medical Center
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
PeterPutman
PhD
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Peter Putman, PhD
Role: PRINCIPAL_INVESTIGATOR
Leiden University, The Netherlands
References
Explore related publications, articles, or registry entries linked to this study.
Barry RJ, Clarke AR, Johnstone SJ. A review of electrophysiology in attention-deficit/hyperactivity disorder: I. Qualitative and quantitative electroencephalography. Clin Neurophysiol. 2003 Feb;114(2):171-83. doi: 10.1016/s1388-2457(02)00362-0.
Bishop SJ. Trait anxiety and impoverished prefrontal control of attention. Nat Neurosci. 2009 Jan;12(1):92-8. doi: 10.1038/nn.2242. Epub 2008 Dec 14.
Bulte I, Onghena P. An R package for single-case randomization tests. Behav Res Methods. 2008 May;40(2):467-78. doi: 10.3758/brm.40.2.467.
Derryberry D, Reed MA. Anxiety-related attentional biases and their regulation by attentional control. J Abnorm Psychol. 2002 May;111(2):225-36. doi: 10.1037//0021-843x.111.2.225.
Eysenck MW, Derakshan N, Santos R, Calvo MG. Anxiety and cognitive performance: attentional control theory. Emotion. 2007 May;7(2):336-53. doi: 10.1037/1528-3542.7.2.336.
Gevensleben H, Holl B, Albrecht B, Vogel C, Schlamp D, Kratz O, Studer P, Rothenberger A, Moll GH, Heinrich H. Is neurofeedback an efficacious treatment for ADHD? A randomised controlled clinical trial. J Child Psychol Psychiatry. 2009 Jul;50(7):780-9. doi: 10.1111/j.1469-7610.2008.02033.x. Epub 2009 Jan 12.
Knyazev GG, Slobodskaya HR. Personality trait of behavioral inhibition is associated with oscillatory systems reciprocal relationships. Int J Psychophysiol. 2003 Jun;48(3):247-61. doi: 10.1016/s0167-8760(03)00072-2.
Leins U, Goth G, Hinterberger T, Klinger C, Rumpf N, Strehl U. Neurofeedback for children with ADHD: a comparison of SCP and Theta/Beta protocols. Appl Psychophysiol Biofeedback. 2007 Jun;32(2):73-88. doi: 10.1007/s10484-007-9031-0. Epub 2007 Mar 14.
Lofthouse N, Arnold LE, Hersch S, Hurt E, DeBeus R. A review of neurofeedback treatment for pediatric ADHD. J Atten Disord. 2012 Jul;16(5):351-72. doi: 10.1177/1087054711427530. Epub 2011 Nov 16.
Putman P, van Peer J, Maimari I, van der Werff S. EEG theta/beta ratio in relation to fear-modulated response-inhibition, attentional control, and affective traits. Biol Psychol. 2010 Feb;83(2):73-8. doi: 10.1016/j.biopsycho.2009.10.008. Epub 2009 Nov 6.
Putman P, Verkuil B, Arias-Garcia E, Pantazi I, van Schie C. EEG theta/beta ratio as a potential biomarker for attentional control and resilience against deleterious effects of stress on attention. Cogn Affect Behav Neurosci. 2014 Jun;14(2):782-91. doi: 10.3758/s13415-013-0238-7.
Schutter DJ, Knyazev GG. Cross-frequency coupling of brain oscillations in studying motivation and emotion. Motiv Emot. 2012 Mar;36(1):46-54. doi: 10.1007/s11031-011-9237-6. Epub 2011 Jul 31.
Spielberger, C. D. (1983). Manual for the State-Trait Anxiety Inventory STAI (form Y)(
Studer P, Kratz O, Gevensleben H, Rothenberger A, Moll GH, Hautzinger M, Heinrich H. Slow cortical potential and theta/beta neurofeedback training in adults: effects on attentional processes and motor system excitability. Front Hum Neurosci. 2014 Jul 24;8:555. doi: 10.3389/fnhum.2014.00555. eCollection 2014.
Ter Kuile MM, Bulte I, Weijenborg PTM, Beekman A, Melles R, Onghena P. Therapist-aided exposure for women with lifelong vaginismus: a replicated single-case design. J Consult Clin Psychol. 2009 Feb;77(1):149-159. doi: 10.1037/a0014273.
van der Ploeg, H. M., Defares, P. B., & Spielberger, C. D. (1981). Handleiding bij de zelf-beoordelings vragenlijst: een Nederlandstalige bewerking van Spielberger state-trait anxiety inventory STAI-DY. Addendum 1981. Swets & Zeitlinger.
Vernon DJ. Can neurofeedback training enhance performance? An evaluation of the evidence with implications for future research. Appl Psychophysiol Biofeedback. 2005 Dec;30(4):347-64. doi: 10.1007/s10484-005-8421-4.
Doppelmayr, M., & Weber, E. (2011). Effects of SMR and theta/beta neurofeedback on reaction times, spatial abilities, and creativity. Journal of Neurotherapy, 15(2), 115-129.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
NFTLeiden
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.